Exploring antibody-drug conjugates (ADCs) in lung cancer

The LUMINOSITY Trial: Exploring c-Met and SEZ6 Targets in the Future of ADCs for NSCLCПодробнее

Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and ...Подробнее

Advances in Antibody-Drug Conjugates Presentation by Advaith Dinesh at Polygence's SymposiumПодробнее

The exciting future of targeted therapies – Exploring new ways to target cancer cellsПодробнее

Novel targeted therapies for NSCLC: Exploring HER2 dysregulationПодробнее

Exploring available third-line treatment options for R/R DLBCL: CAR-T, bispecifics, ADCs & mAbsПодробнее

Exploring novel therapeutics in lung cancer: insights from BTOG 2024Подробнее